Anti-inflammatory effects of macrolide antibiotics

European Journal of Pharmacology

Volumn 429, Issue 1-3, 2001, Pages 209-229

  Uli, Ognjen ^a   Erakovi, Vesna ^a   Parnham, Michael J ^a  

^a PLIVA CROATIA LTD   (Croatia)

Author keywords

Leukocyte; Macrolide; Neutrophil

Indexed keywords

AZITHROMYCIN; BAFILOMYCIN; CETHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; CONCANAMYCIN A; CYCLOSPORIN; CYTOKINE; DACTINOMYCIN; DIRITHROMYCIN; DOXORUBICIN; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; HMR 3004; JOSAMYCIN; MACROLIDE; MIDECAMYCIN; NITRIC OXIDE; RANTES; RAPAMYCIN; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; TACROLIMUS; TELITHROMYCIN; TILMICOSIN; VINBLASTINE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ASTHMA; CHRONIC SINUSITIS; CLINICAL STUDY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DEGRANULATION; DRUG EFFECT; DRUG MECHANISM; HOST RESISTANCE; HUMAN; IN VITRO STUDY; INFECTION; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; LUNG NON SMALL CELL CANCER; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; RESPIRATORY TRACT DISEASE; REVIEW; SMALL AIRWAY DISEASE; TREATMENT INDICATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; INFLAMMATION; MACROLIDES;

EID: 0035840852     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01321-8     Document Type: Review

References (234)

1. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation
2. Comparison of various macrolides for stimulation of human neutrophil degranulation
3. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatide phosphohydrolase transduction pathway. L-Cladinose is involved both in alteration of neutrophil function and modulation of this transductional pathway
4. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells
5. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5
6. Macrolide antibiotics as anti-inflammatory agents: Roxithromycin in an unexpected role
7. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-derived superoxide generation and auto-oxidation
8. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
9. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells
10. Erythromycin shortens neutrophil survival by accelerating apoptosis
11. Is there a role for macrolides in arthritis?
12. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
13. Leukokinetic studies: III. The distribution of granulocyte in the blood of normal subjects
14. Leukokinetic studies: IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects
15. Function of human alveolar macrophages after a 3-day course of azithromycin in healthy volunteers
16. Macrolides, asthma, inflammation and infection
17. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules
18. NF-κB: Ten years after
19. Differential modulation of cytokine production by macrolides: Interleukin-6 production is increased by spiramycin and erythromycin
20. Effects des antibiotiques sur la production de cytokines par les monocytes humains
21. Nitric oxide blocks nuclear factor-κB activation in alveolar macrophages
22. Penetration of macrolides into pulmonary sites of infections
23. Stimulation with cytokines enhances penetration of azithromycin into human macrophages
24. In vitro and in vivo interleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vovo leukocyte chemiluminescence
25. Effects of rokitamycin on phagocytosis and release of oxidant radicals of human polymorphonuclear leukocytes
26. Direct neutrophil migration to IL-8 is increased in cystic fibrosis: A study of the effect of erythromycin
27. Infection, inflammation and coronary artery disease: More than just an association?
28. Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes
29. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells
30. Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture
31. Potential role of macrolides in the treatment of asthma
32. The anti-inflammatory effect of erythromycin and its derivatives: Special reference to nasal polyposis and chronic sinusitis
33. Regulation of granulocyte apoptosis and implication for anti-inflammatory therapy
34. Tilmicosin induces apoptosis in bovine peripheral neutrophils in the presence or in absence of Pasteurella hemolytica and promotes neutrophil phagocytosis by macrophages
35. The role of nuclear factor kappa B in pulmonary diseases
36. Effects of azithromycin on ozone-induced airway neutrophil and cytokine release
37. Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappa B prevents carrageenin-induced inflammation in rat hind paw
38. Erythromycin suppresses nuclear factor-kappa B and activator protein-1 activation in human bronchial epithelial cells
39. Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases
40. FK506, an immunosuppressant targeting calcineurin function
41. TNF-alpha-induced suppression of polymorphonuclear leukocyte apoptosis is mediated through interleukin-8 production
42. A placebo-controlled, double-blind trial of erythromycin in the treatment of acute bronchitis
43. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: The WIZARD (weekly intervention with zithromax (azithromycin) for atherosclerosis and its related disorders) trial
44. Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice
45. Azithromycin: Indications for the future?
46. Evaluation of the effect of erythromycin on otitis media with effusion in experimental rat models
47. The effect of antimicrobial agents on leukocyte chemotaxis
48. Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium, in vitro
49. The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro
50. Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes
51. Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?
52. +-ATPase
53. Antibiotics and neutrophil function - Potential immunomodulating activities
54. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection
55. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro
56. +-ATPase
57. Effects of a 17-membered azalide on tumor cell growth
58. Antitumor effects of erythromycin in mice
59. Adjuvant effects of clarithromycin on chemotherapy for murine lung cancer
60. Anti-inflammatory activity of chlarithromycin in the treatment of adults with chronically-inflamed sinus mucosa
61. Interactions of dirithromycin with human polymorphonuclear leukocytes
62. Influence of pentoxifylline and its derivatives on antibiotic uptake and superoxide generation by human phagocytic cells
63. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes
64. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis
65. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis
66. +-ATPase inhibitor in B lineage cells
67. Granulocyte apoptosis and its role in the resolution and control of lung inflammation
68. Effects of antibiotics on human polymorphonuclear neutrophil (PMN) apoptosis
69. Role of inducible nitric oxide synthesis in the regulation of leucocyte recruitment
70. Reversal of drug resistance by erythromycin: Erythromycin increases the accumulation of actinomycin D and deoxorubicin in multidrug-resistant cells
71. C kinase activation and induction of HL-60 promyelocytic leukemia cell differentiation caused by roxithromycin
72. Neutrophil chemotactic activity in cryptogenic organizing pneumonia and the response to erythromycin
73. Anti-inflammatory activity of macrolide antibiotics
74. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients
75. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells
76. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor α production by human monocytes in vitro
77. The effect of erythromycin on human peripheral neutrophil apoptosis
78. Expression of nuclear factor-kappaB in Heliobacter pylori-infected gastric mucosa detected with southwestern histochemistry
79. Description and status of the azithromycin and coronary events study (ACES)
80. Long-term azithromycin may improve lung function in child cystic fibrosis
81. Rapamycin inhibits didemnin B-induced apoptosis in Human HL-60 cells: Evidence for the possible involvement of FK506-binding protein 25
82. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis
83. The macrolide antibacterial roxithromycin reduces bronchial hyperresponsiveness and superoxide anion production by polymorphonuclear leukocytes in patients with asthma
84. Effect of FK506 on ATP-induced intracellular calcium oscillations in cow tracheal epithelium
85. Polyketide synthesis: Prospects for hybrid antibiotics
86. Novel macrolides through genetic engineering
87. Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro
88. +-ATPases: Targets for drug discovery?
89. Anti-lymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A
90. Effects of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells
91. Effects of clarithromycin and azithromycin on production of cytokines by human monocytes
92. Clinical effect of low-dose, long-term roxithromycin chemotherapy in patients with chronic sinusitis
93. Enhanced interleukin production after long-term administration of erythromycin stearate
94. Proliferation of erythromycin-stimulated mouse peritoneal macrophages in the absence of exogenous growth factors
95. Alterations of host response by a long-term treatment of roxithromycin
96. Transfection of interleukin-8 increases angiogenesis and tumorogenesis of human gastric carcinoma cells in nude mice
97. Apoptosis, oxidative metabolism and interleukin-8 production on human neutrophils exposed to azithromycin: Effects of Streptococcus pneumoniae
98. Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages
99. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors
100. Antiasthmatic activity of macrolide antibiotic, roxithromycin: Analysis of possible mechanism in vitro and in vivo
101. Mice lacking c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
102. Effect of roxithromycin on peripheral neutrophil adhesion molecules in patients with chronic lower respiratory tract disease
103. Anti-inflammatory activity of macrolides: A new therapeutic potential?
104. Immunological effects of macrolides
105. Interference of antibacterial agents with phagocyte functions: Immunomodulation or "immuno-fairy tales"?
106. Immunomodulation by macrolide antibiotics
107. Interaction of antibiotics with the phagocyte oxidative burst
108. Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils
109. Azithromycin impact on neutrophil oxidative metabolism depends on exposure time
110. Time and concentration dependent influence of dirithromycin on neutrophils oxidative burst
111. Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils
112. Mucolytic effect of chlarithromycin once-a day in chronic bronchitis
113. Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin
114. Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells
115. Chemistry and mode of action of macrolides
116. Phagocyte uptake and transport of azithromycin
117. The anti-inflammatory effects of erythromycin in zymosan-induced peritonitis of mice
118. Significant survival benefit to patients with advanced non-small-cell lung cancer from treatment with clarithromycin
119. Chlamydia pneumoniae activates nuclear factor kappa B and activator protein 1 in human vascular smooth muscle and induces cellular proliferation
120. The new ketolide HMR3647 accumulates in the azurophil granule of human polymorphonuclear cells
121. Neutrophil-induced endothelial cell damage: Inhibition by a 14-membered ring macrolide through the action of nitric oxide
122. Release of nitric oxide and expression of constitutive nitric oxide synthase of human endothelial cells: Enhancement by a 14-membered ring macrolide
123. Effects of clarithromycin on cultured human nasal epithelial cells and fibroblast
124. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma
125. Interactions of macrolide antibiotics (erythromycin, A, roxithromycin, erythromycylamine (dirithromycin), and azithromycin) with phospholipids: Computer-aided conformational analysis and studies on a cellular and cell culture models
126. Modulatory effects of antibiotics on cytokine production by human monocytes in vitro
127. In vitro effects of spiramycin on IL-1 beta production by human LPS-stimulated mononuclear cells
128. Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro
129. Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides
130. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
131. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the ACADEMIC study
132. Long-term low dose administration of erythromycin to patients with diffuse panbronchiolitis
133. A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL-60 cells by producing multinucleate cells
134. Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection
135. Reduced nasal nitric oxide in diffuse panbronchiolitis
136. Nitric oxide as a secretory product of mammalian cells
137. Role of nitric oxide synthesis in macrophage antimicrobial activity
138. Nitric oxide synthases: Roles, tolls, and controls
139. Erythromycin-induced suppression of pulmonary antibacterial defenses: A potential mechanism of superinfection in the lung
140. Reduced intracellular activity of antibiotics against Listeria monocytogenes in multidrug resistant cells
141. +-ATPase induce apoptotic cell death
142. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts
143. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts
144. Influence of azithromycin on human neutrophil degranulation
145. Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains
146. Role of interleukin-8 and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases
147. Macrolides reduce the expression of surface Mac-1 molecule on neutrophil
148. Macrolides with gastrointestinal motor stimulating activity
149. Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture
150. Effects of antimicrobial drugs on human neutrophil-microbe interactions
151. Factors affecting the intracellular accumulation and activity of azithromycin
152. Azithromycin uptake by tissue cultured epithelial cells
153. Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pi with human neutrophils in vitro
154. Highlights of recent research of the synthesis of ketolide antibiotics
155. Macrolides and immunity: Effects of erythromycin and spiramycin on human mononuclear cell proliferation
156. Macrolide antibiotics as biological response modifiers
157. Erythromycin inhibits LPS induced inflammation in rats
158. Interleukin-1 beta, tumor necrosis factor alpha, and interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: A potential mechanism of macrolide therapy
159. Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase
160. Apoptolidin, a selective cytotoxic agent, is an inhibitor of F(0)F(1)-ATPase
161. Therapeutic effect of clarithromycin on a transplanted tumor in rats
162. Differential modulatory effects of clarithromycin on the production of cytokines by a tumor
163. Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro
164. Macrophage recognition of senescent neutrophils
165. Comparative anti-inflammatory effects of roxithromycin azithromycin and clarithromycin
166. In vivo uptake of azithromycin in human coronary plaques
167. Azithromycin: Single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome - A randomized study
168. The mechanism of action of cyclosporin A and FK506
169. Intravenous infusion of erythromycin in healthy humans results in a reduced capacity of peripheral blood leukocytes to produce chemokines upon stimulation with Streptococcus pneumoniae
170. Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae
171. The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease
172. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune response
173. Effect of 14-membered ring macrolide therapy on chronic respiratory tract infection and polymorphonuclear leukocyte activity
174. Erythromycin treatment in diffuse panbronchiolitis
175. Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma
176. Erythromycin in rheumatoid arthritis
177. Effects of macrolide antibiotics on neutrophil function in human peripheral blood
178. Roxithromycin stimulates the mucociliary activity of the Eustachian tube and modulates neutrophil activity in the healthy guinea pig
179. Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages
180. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production
181. Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo
182. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients
183. Inhibitory effects of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells
184. IL-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics
185. Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis
186. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy
187. Immunological and anti-inflammatory effects of clarithromycin: Inhibition of interleukin 1 production of murine peritoneal macrophages
188. Erythromycin suppresses interleukin-6 expression by human bronchial epithelial cell: A potential mechanism of its anti-inflammatory action
189. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells
190. Effect of erythromycin on ciliary motility in rabbit airway epithelium, in vitro
191. Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea
192. Effects of roxithromycin and erythromycin on interleukin 8-induced neutrophil recruitment and goblet cell secretion in guinea pig tracheas
193. Lipopolysaccharide-induced goblet cell hypersecretion in the guinea pig trachea: Inhibition by macrolides
194. Effects of macrolide antibiotics on iNOS gene expression and NO production by alveolar macrophages
195. Macrolide antibiotics protect against immune complex-induced lung injury in rats: Role of nitric oxide from alveolar macrophages
196. Interactions of oflaxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells
197. Chemokines and atherosclerosis
198. Clarithromycin suppresses proliferation of rat nasal epithelium exposed to endotoxin
199. In vivo administration of azithromycin affects lymphocytes activity in vitro
200. Transcriptional factor decoy for NFκB inhibits TNF-α induced cytokine and adhesion molecule expression in vivo
201. In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes
202. Diffuse panbronchiolits: Diagnosis and treatment
203. Combinatorial biosynthesis of «unnatural» natural products: The polyketide example
204. Macrolide antibiotics azithromycin and erythrmycylamine perturb the early stages of endocytosis in phagocytic and nonphagocytic cells
205. Anti-inflammatory action of erythromycin
206. Investigation of the uptake of HMR 3647, HMR 3004 and roxithromycin by myelomonocytic cell lines
207. Cellular accumulation of the new ketolides RU 64004 by human neutrophils: Comparison with that of azithromycin and roxithromycin
208. Interactions between HMR3647, a new ketolide, and human polymorphonuclear neutrophils
209. Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils
210. The anti-inflammatory effects of macrolides
211. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo
212. Pharmacological manipulation of granulocyte apoptosis: Potential therapeutic targets
213. NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro
214. Erythromycin. A microbial and clinical perspective after 30 years of clinical use
215. Effects of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry
216. Bacterial infection induces nitric oxide synthesis in human neutrophils
217. Interaction of azithromycin and human phagocytic cells
218. Uptake and subcellular distribution of azithromycin in human phagocytic cells
219. Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions
220. Comparison of macrolide antibiotics
221. Neutrophils: Molecules, functions and pathophysiological aspects
222. Highlights of semi-synthetic developments from erythromycin A
223. Effects of macrolide antibiotics on macrophage functions
224. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage
225. Interleukin-8 participates in angiogenesis in no-small cell but not small cell carcinoma of the lung
226. Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic
227. Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells
228. Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells
229. Inhibition of neutrophil-derived IL-8 production caused by erythromycin 201 derivative: Modification of the activities by the 5-position desosamine side chain
230. Review of macrolides and ketolides: Focus on respiratory tract infections
231. Effects of erythromycin on ATP-induced intracellular calcium response in A549 cells